PatientsVille.com Logo

Sunburn and Olay

PatientsVille

Sunburn Symptoms and Causes

Ultraviolet (UV) rays are an invisible form of radiation. They can pass through your skin and damage your skin cells. Sunburns are a sign of skin damage. Suntans aren't healthy, either. They appear after the sun's rays have already killed some cells and damaged others. UV rays can cause skin damage during any season or at any temperature. They can also cause eye problems, wrinkles, skin spots, and skin cancer.

To protect yourself

  • Stay out of the sun when it is strongest (between 10 a.m. and 2 p.m.)
  • Use sunscreen with an SPF of 15 or higher
  • Wear protective clothing
  • Wear wraparound sunglasses that provide 100 percent UV ray protection
  • Avoid sunlamps and tanning beds

Check your skin regularly for changes in the size, shape, color, or feel of birthmarks, moles, and spots. Such changes are a sign of skin cancer.

Food and Drug Administration

Check out the latest treatments for sunburn

sunburn treatment research studies

Olay clinical trials, surveys and public health registries


Find Drug Side Effect reports



Olay Side Effects

Eyelid Oedema (69)
Skin Disorder (40)
Blister (35)
Condition Aggravated (31)
Swelling Face (30)
Dyspnoea (25)
Erythema (17)
Skin Exfoliation (14)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Sunburn Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Lotion) in the Relief of Sunburn Related Symptoms
Condition: Sunburn
Interventions: Drug: Dexchlorpheniramine 1% lotion;   Drug: Dexchlorpheniramine 1% cream
Outcome Measures: Pruritus intensity evaluated with a 10-point Visual Analogic Scale (VAS);   Composite clinical evaluation of erythema, pruritus and burning sensation performed by the investigator using a 4-point scale for each one of the variables (absent, mild, moderate, intense).
2 Unknown  Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Gel) in the Relief of Sunburn Related Symptoms
Condition: Sunburn
Interventions: Drug: Dexchlorpheniramine 1% gel;   Drug: Dexchlorpheniramine 1% cream
Outcome Measures: Pruritus intensity evaluated with a 10-point Visual Analogic Scale (VAS);   Composite clinical evaluation of erythema, pruritus and burning sensation performed by the investigator using a 4-point scale for each one of the variables (absent, mild, moderate, intense).
3 Unknown  The Sun Protection Effect and Efficacy in Treatment of Sunburn Using Topical Corticosteroids.
Condition: Sunburn
Intervention: Drug: corticosteroids
Outcome Measure:
4 Unknown  The Effect of Remifentanil on Established Sunburn-induced Hyperalgesia in Human Volunteers
Condition: Hyperalgesia
Interventions: Drug: Midazolam;   Drug: Remifentanil
Outcome Measures: Area of pin prick hyperalgesia;   Stimulus-response (SR) function to a set of modified rigid von Frey filaments (8-512 mN);   Heat pain threshold within the area of mechanical hyperalgesia;   Mechanical pain threshold within the area of pin prick hyperalgesia, area of dynamic allodynia to brush;   Adverse effects
5 Unknown  The Effect of High-dose Remifentanil on Established Sunburn-induced Hyperalgesia in Human Volunteers (HighDose RemiSun)
Condition: Hyperalgesia
Interventions: Drug: Remifentanil;   Drug: Midazolam
Outcome Measures: Measure: Area of pin prick hyperalgesia;   Stimulus-response (SR) function to a set of modified rigid von Frey filaments (8-512 mN);   Heat pain threshold within the area of mechanical hyperalgesia;   Mechanical pain threshold within the area of pin prick hyperalgesia, area of dynamic allodynia to brush;   Adverse effects
6 Not yet recruiting Sun Protection of Kidney Transplant Recipients
Conditions: Unspecified Complication of Kidney Transplant;   Disorder Related to Renal Transplantation
Intervention: Behavioral: Internet-based sun protection education
Outcome Measures: Use of sun protection;   Level of sun burn or skin irritation from the sun;   Forearm skin pigment
7 Recruiting Evaluation of Photosensitivity in Dabrafenib or Vemurafenib Treated Metastatic Melanoma Patients - a Phase IIa/IIb Study
Condition: Metastatic Melanoma (Carrying BRAF V600 Mutation)
Interventions: Drug: Dabrafenib;   Drug: Vemurafenib
Outcome Measures: Degree of Solar Dermatitis due to Standardized UV Exposure in Patients treated with Dabrafenib;   Degree of Solar Dermatitis due to Standardized UV Exposure in Patients treated with Dabrafenib or Vemurafenib;   Number of Participants with Adverse Events treated with dabrafenib;   Best overall response rates and progression free survival in patients treated with dabrafenib or vemurafenib using RECIST v1.1 criteria
8 Recruiting Remote Ischemic Preconditioning Mechanism Study
Condition: Pain
Intervention: Device: Remote Ischemic Preconditioning, Capsaicin, UV-B
Outcome Measures: Areas of hyperalgesia and allodynia to mechanical stimuli.;   Pain intensity and unpleasantness to mechanical stimuli;   Presence of parathesias where RIPC was used
9 Recruiting Treatment of Neonatal Jaundice With Filtered Sunlight Phototherapy: Safety and Efficacy in African Neonates
Condition: Jaundice, Neonatal
Interventions: Procedure: Window tinting film for filtered sunlight phototherapy;   Device: conventional phototherapy
Outcome Measures: Change in Serum Bilirubin;   Incidence of Sunburn and Dehydration;   Non-inferiority of sunlight phototherapy;   Number of participants requiring intervention such as exchange blood transfusion
10 Recruiting Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome
Conditions: Meibomian Gland Dysfunction;   Dry Eye Syndrome
Interventions: Device: Cutera Xeo Platform-Limelight;   Device: Sciton BroadBand Light
Outcome Measure: Anatomical improvement of the meibomian glands and their secretions.
11 Recruiting Adaption of the Skin Sun Sensitivity Scale
Condition: Skin Diseases
Intervention:
Outcome Measures: Melanin Index by Spectrophotometry;   Participant Self-Report of Fitzpatrick Skin Type;   Assessment of Ease of Freckling as a Child and Ethnicity;   Assessment of Fitzpatrick Skin Type using the Adapted Skin Phototype Measure
12 Recruiting Comparative Trial of Cryotherapy Versus Caphosol Versus Saline Solution Mouth Washes for the Prevention of Oral Mucositis in Patients With Multiple Myeloma Undergoing Hematopoietic Stem Cell Transplantation
Conditions: Mucositis;   Multiple Myeloma
Interventions: Drug: 0.9% Sodium Chloride irrigation solution;   Other: Cryotherapy (ice chips);   Device: Calcium phosphate (Caphosol) Ca2+/PO43- mouth rinse
Outcome Measure: Incidence of severe oral mucositis
13 Unknown  Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol
Condition: Vitiligo
Interventions: Genetic: Sequential phototherapy;   Procedure: Continuous phototherapy
Outcome Measure: The percentage of repigmentation on the target lesions will be evaluated at the end of each treatment in both groups.
14 Recruiting Family Study of Melanoma in Italy
Conditions: Melanoma;   Dysplastic Nevi;   Melanocytic Nevi
Intervention:
Outcome Measure: Defining the clinical spectrum and natural history of familial melanoma and susceptibility states over multiple generations